TECHNOLOGY SUMMARY

Sphingosine-1 Phosphate (S1P) is an enzyme in humans that has been shown to be upregulated by viruses to help them replicate and spread infection. Our work shows that inhibitors of S1P can protect from infection with Influenza A and other clinically relevant viral infections.

AREA/MATURITY/AWARDS

Primary Application Area: Biotech, Pharma, Health

Technology Development Status: Concept

Technology Readiness Level: TRL 3

Vetted Programs/Awards: University of Missouri has been issued US Patent 9,687,487 covering this technology.

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Website: https://missouri.edu/

Showcase Booth #: T63

MARKET KEYWORDS

Market Keywords: Anti-viral, Influenza, Viral